Complete the 6-month observational trial extension of ALTISSIMO
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 5 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Complete 6-month observational trial extension of ALTISSIMO by June 2021, with topline data expected in 3Q 2021.”
What we found
Evidence strength A What the grades mean
The August 2021 8-K reports the six-month ALTISSIMO extension was completed, with the last patient exiting in June 2021, before the June 2021 deadline.
-
A Graybug Vision, Inc. 8-K filed 2021-08-11
“Completed six-month extended observation period of ALTISSIMO Phase 2b trial in wet AMD— 28 of the 50 patients who completed their Month 12 visit were eligible” ✓ confirmed on the page
-
A Graybug Vision, Inc. 8-K filed 2021-08-11
“In June 2021, the last patient exited the extension period, with 60% of GB-102 1 mg patients requiring no supportive therapy during the six-month extension period.” ✓ confirmed on the page
-
A Graybug Vision, Inc. 10-K filed 2022-03-11
“We reported topline data from the Extension Study in September 2021.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- ALTISSIMO 6-month observational trial extension
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Graybug Vision, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CALC-025255 · Corrections policy